Order Article Reprints

Bartaula-Brevik S, Leitch C, Hernandez-Valladares M, Aasebø E, Berven FS, Selheim F, Brenner AK, Rye KP, Hagen M, Reikvam H, et al. Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. Journal of Clinical Medicine. 2023; 12(17):5546. https://doi.org/10.3390/jcm12175546

Bartaula-Brevik, Sushma, Calum Leitch, Maria Hernandez-Valladares, Elise Aasebø, Frode S. Berven, Frode Selheim, Annette K. Brenner, Kristin Paulsen Rye, Marie Hagen, Håkon Reikvam, and et al. 2023. "Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity" Journal of Clinical Medicine 12, no. 17: 5546. https://doi.org/10.3390/jcm12175546

Bartaula-Brevik, S., Leitch, C., Hernandez-Valladares, M., Aasebø, E., Berven, F. S., Selheim, F., Brenner, A. K., Rye, K. P., Hagen, M., Reikvam, H., McCormack, E., Bruserud, Ø., & Tvedt, T. H. A. (2023). Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. Journal of Clinical Medicine, 12(17), 5546. https://doi.org/10.3390/jcm12175546